Sectors
ANAB
AnaptysBio, Inc.
57.30
1 x 53.77
1 x 56.87
bid
ask
+
1.84
3.31%
09:39 AM
timesize
| Ytd | 77.31% | |
| 1y | 329.89% |
56.09
day range
57.30
11.40
52 week range
72.36
| Open | 56.79 | Prev Close | 55.47 | Low | 56.09 | High | 57.30 | Mkt Cap | 1.70B |
| Vol | 16.05K | Avg Vol | 642.42K | EPS | -1.08 | P/E | -53.06 | Forward P/E | 10.81 |
| Beta | 0.72 | Short Ratio | 6.75 | Inst. Own | 102.61% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 57.28 | 200-d Avg | 43.22 | 1yr Est | 87.09 |
| Income Statement | |||
| Total Revenue | 25.56M | ||
| Revenues (USD) | 25.56M | ||
| Gross Profit | 25.56M | ||
| Operating Expenses | 60.19M | ||
| Research and Development Expense | 33.99M | ||
| Selling, General and Administrative Expense | 26.20M | ||
| Operating Income | -34.64M | ||
| Income Tax Expense | 40.00K | ||
| Net Income | -52.88M | ||
| Net Income Common Stock | -52.88M | ||
| Net Income Common Stock (USD) | -52.88M | ||
| Consolidated Income | -52.88M | ||
| Earnings per Basic Share | -1.84 | ||
| Earnings per Basic Share (USD) | -1.84 | ||
| Earnings per Diluted Share | -1.84 | ||
| Earning Before Interest & Taxes (EBIT) | -52.84M | ||
| Earning Before Interest & Taxes (USD) | -52.84M | ||
| Weighted Average Shares | 28.69M | ||
| Weighted Average Shares Diluted | 28.69M | ||
| Balance Sheet | |||
| Cash and Equivalents | 248.47M | ||
| Cash and Equivalents (USD) | 248.47M | ||
| Investments | 37.99M | ||
| Investments Current | 37.99M | ||
| Trade and Non-Trade Receivables | 25.75M | ||
| Current Assets | 316.11M | ||
| Property, Plant & Equipment Net | 13.32M | ||
| Total Assets | 329.68M | ||
| Debt Current | 2.12M | ||
| Total Debt | 277.36M | ||
| Current Liabilities | 41.70M | ||
| Debt Non-Current | 275.24M | ||
| Total Liabilities | 316.94M | ||
| Accumulated Retained Earnings (Deficit) | -825.44M | ||
| Accumulated Other Comprehensive Income | -146.00K | ||
| Shareholders Equity | 12.75M | ||
| Shareholders Equity (USD) | 12.75M | ||
| Assets Non-Current | 13.58M | ||
| Total Debt (USD) | 277.36M | ||
| Liabilities Non-Current | 275.24M | ||
| Trade and Non-Trade Payables | 7.52M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 610.00K | ||
| Net Cash Flow from Financing | 1.21M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 10.27M | ||
| Capital Expenditure | -17.00K | ||
| Issuance (Purchase) of Equity Shares | 14.02M | ||
| Issuance (Repayment) of Debt Securities | -12.81M | ||
| Net Cash Flow from Investing | 34.98M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 35.00M | ||
| Net Cash Flow from Operations | -25.92M | ||
| Share Based Compensation | 14.22M | ||